Aqua Bio Technology — Director's Dealing 2026

Mar 16, 2026

Aqua Bio Technology ASA: Primary insider notifications

Aqua Bio Technology ASA: Primary insider notifications

Reference is made to the stock exchange notice from Aqua Bio Technology ASA

("ABTEC" or the "Company") published on 13 March 2026 regarding the

Extraordinary General Meeting approving a NOK 50 million debt conversion with

the issuance of 10,000,000 new shares (the "New Shares") in the Company, at a

subscription price of NOK 5.00 per New Share (the "Debt Conversion").

The following primary insiders or close associates of primary insiders have

subscribed for and been allocated New Shares:

· Norlane AS, a company controlled by ABTEC chairman Roger Sedal, has been

allocated 1,662,162 New Shares in the Debt Conversion, for a total

subscription amount of NOK 8,310,810. Following this and upon completion of

the Debt Conversion, Norlane AS will hold 1,828,368 shares in the Company,

corresponding to 12.0% of the shares and votes in the Company; and

· Terabyte Holding AS, a company controlled by ABTEC board member Terje Blytt,

has been allocated 2,310,811 New Shares in the Debt Conversion, for a total

subscription amount of NOK 11,554,055. Following this and upon completion of

the Debt Conversion, Terabyte Holding AS will hold 2,638,211 shares in the

Company, corresponding to 17.3% of the shares and votes in the Company

Please see the attached notification forms for further information.

The calculations in this notice are based on a total number of shares in the

Company of 15,227,935 following completion of the Debt Conversion, and

registration of the shares in the Norwegian Register of Business Enterprises.

This information is subject to the disclosure requirements pursuant to MAR

article 19.

Contacts

Kristian Flaten

CEO & CFO

Aqua Bio Technology ASA

Phone: +47 9509 2322

Email: kf@aquabiotech.no

About Us

Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in

skincare and nonfood. The group has distribution towards B2C and B2B, and

offers freight, customs, and logistics services. The group also develops

sustainable biotechnology for use in skincare products. Aqua Bio Technology is

listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act §

5-12 and MAR. The information was submitted for publication, through the

agency of the contact persons set out above, at 2026-03-16 07:30 CET.